• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Zambia Pharmaceuticals and Healthcare Report Q2 2012 Product Image

Zambia Pharmaceuticals and Healthcare Report Q2 2012

  • Published: February 2012
  • Region: Zambia
  • 38 Pages
  • Business Monitor International

Zambia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Zambia's pharmaceuticals and healthcare industry.

BMI believe Zambia is rapidly becoming one of the most promising markets in Sub-Saharan Africa. An increased focus on healthcare and preventing corruption has attracted donations and loans from the international community that, alongside a record healthcare budget, will help to revolutionise its provision of healthcare and its focus on human capital. Decentralising healthcare provision should expand access substantially. In the short term, this will not benefit multinational drugmakers a great deal as the majority of the rural population is very poor and generic drugs will continue to dominate prescription patterns. However, in the longer term, it will drive sales of drugs as the country continues to develop.

Headline Expenditure Projections Pharmaceuticals: ZMK950bn (US$196mn) in 2011 to ZMK1,128bn (US$231mn) in 2012; +18.7% in local currency terms and +18.2% in US dollar terms. READ MORE >

BMI Industry View

Industry Business Environment Overview
Table: Middle East And Africa (MEA) – Regional Pharmaceutical Risk Reward Ratings For Q212

Pharmaceutical Risk/Reward Ratings
Rewards
Risks

Market Summary

Government Healthcare Reform

Regulatory Regime

Industry Forecast Scenario
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales Indicators 2008-2016
Healthcare Market Forecast
Table: Healthcare Expenditure Indicators 2008-2016
Table: Healthcare Governmental Indicators 2008-2016
Table: Healthcare Private Indicators 2008-2016

Glossary

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos